A new discovery shows that the malaria parasite survival in the human bloodstream has a lot to do with a single, crucial chemical that the parasite produces internally. This new discovery provides a powerful tool for new malaria treatment, which infects hundreds of millions of people around the world each year and claims about a million lives — mostly children.
Read the full story (sciencedaily)
Researchers at Lancaster University says that a new drug which can prevent the development of Alzheimer’s disease could be tested on patients within six years.
Read the full story (BBC)
Doctors at the University of Pennsylvania, who tried a new treatment on 3 patients, say this treatment made the most common type of leukemia completely disappear in two of the patients and reduced it by 70 percent in the third.
Read the full story (MSNBC)
Since the year of 2007, and due to an increase of 65% in screening at the USA, death rates from colorectal cancer decreased in 49 states (Only Mississippi had no change in its death rate) and Washington, D.C., with the largest declines in states with the most screening.
Read the full story (Reuters)
The medical team at the University of Alberta Hospital offered a brain cancer patient at the age of 30 to use DCA, a drug used to treat rare metabolic disorders, which also showed the ability to shrink tumors in rats. After 15 months the tumor was gone, 3 other patient who took this drug had their tumors shrink significantly or stop growing.
Read the full story (theglobeandmail)
On week 20 of their pregnancy, doctors told Jessica Browning that her twins are in risk, the twins looked healthy, but their bags were different sizes. Usually, parents have a decision to make to lose one of the twins, but Jessica went under a risky operation in which a hole was made in the thin membrane that separated the twins, allowing the fluid to equalize. Babies were born healthy at 32 weeks.
Read the full story (wlbz2)
A team of scientists from Duke university have shown how a single protein may trigger autistic spectrum disorders by stopping effective communication between brain cells. This study raises hopes of the first effective drug treatments.
Read the full story (BBC)
A handbag made by the handbag company Miche Bag, which is based in Utah, has already raised $700000 for cancer research. $5 of every purchase of this “Hope” handbag is donated to the huntsman cancer institute.
Read the full story (Miche bag blog)
Nathan Saavedra, a 2 years old toddler, was born with a rare birth defect and was in need for a kidney transplant. Chris Doing, a 38-year-old information technology security analyst heard about Nathan and contacted the hospital, after a blood test he was a donor match. On October 25th the 2 operations took place and now, for the first time in his life, Nathan had normal kidney function.
Read the full story (NBC Chicago)
Cyberdyne company from Japan produces a robot device called HAL which gives power to its wearer by anticipating and supporting the user’s body movements. The company is gearing up for mass-production and already started leasing the suit to welfare facilities last year.
Read the full story (Physorg)
